All reports
Pharmaceutical
Obesity & Metabolic
Monthly GLP-1: Metsera, Amylin and Next-Generation Therapies
Code: NSC/PHRM/0003Published May 03, 2026Data window: 6 months
About this report
MET-097i, MET-233i and the race to monthly dosing; impact on adherence and competitive dynamics.
Humans at the core of the analysis
Partner specialist firms, independent domain experts and our in-house analyst team: every report is written and reviewed by humans who cross-check signals, verify sources and prioritise what matters.
Key insights
Request the sample to discover the report's key insights.
Table of contents
The detailed table of contents is shared with the free sample.